Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products Cannabis Investing News
PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program Biotech Investing
MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA) Cannabis Investing News
Lexaria Bioscience and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship Cannabis Investing News
Life Science Big News Roundup: Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc.; Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell; Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations Life Science Investing
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Pharmaceutical Investing
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma Biotech Investing
Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug Cannabis Investing News
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
